◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06540716 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Inspire Medical Systems, Inc. |
| Condition | Obstructive Sleep Apnea |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2024-08 |
| Primary Completion | 2025-08 |
Trial Parameters
Condition Obstructive Sleep Apnea
Sponsor Inspire Medical Systems, Inc.
Study Type INTERVENTIONAL
Phase N/A
Enrollment 44
Sex ALL
Min Age 21 Years
Max Age N/A
Start Date 2024-08
Completion 2025-08
All Conditions
Interventions
Inspire System
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Prospective, multicenter, open-label study designed to confirm device performance of Inspire system in Singapore.
Eligibility Criteria
Main Inclusion Criteria: * Diagnosis of moderate to severe OSA (AHI 15-65) * Failure of, or intolerance to CPAP Main Exclusion Criteria: * Central + mixed apneas \> 25% of total AHI * Presence of complete concentric collapse (CCC) * Compromised neurological control of the upper airway. Other eligibility criteria may apply.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology